CDKN2A rs10810534: What Your Genotype Means
The rs10810534 variant is a common genetic change located in the CDKN2A/B gene region on chromosome 9. It has been statistically associated with an increased risk of developing type 2 diabetes in various human populations.
What each genotype means
Baseline diabetes risk
This genotype represents the common form of the variant at this location. Research suggests that individuals with this genotype do not carry the specific risk-associated allele linked to type 2 diabetes in the CDKN2A/B locus. This is considered the baseline profile for this genetic marker.
This is a common genotype found in the majority of the global population.
Potential increased diabetes risk
Carrying one copy of the T allele is associated with a statistically higher risk of developing type 2 diabetes in various populations. The CDKN2A/B locus is thought to influence diabetes risk by affecting beta-cell function and proliferation, though the evidence for this specific variant remains limited. This association does not mean you will develop the condition, as diabetes risk is influenced by many genetic and lifestyle factors.
This genotype is commonly observed across many ancestral groups.
Elevated diabetes risk
Carrying two copies of the T allele is associated with a higher statistical risk of type 2 diabetes compared to those without the variant. While this variant is linked to the CDKN2A/B gene, which plays a role in pancreatic beta-cell health, the overall impact on individual health is complex and multifactorial. You should discuss your overall metabolic health and diabetes risk factors with your healthcare provider.
This genotype is found at varying frequencies globally, appearing in a significant portion of the population.
Understanding the SNP and Its Location
The variant rs10810534 is a single nucleotide polymorphism (SNP) situated on chromosome 9 at the 9p21.3 locus. This specific region of the human genome is well-studied because it houses the CDKN2A and CDKN2B genes. SNPs are the most common type of genetic variation among people, representing a difference in a single DNA building block, or nucleotide. While many SNPs have no effect on health, researchers track them to identify patterns that may correlate with specific traits or disease risks. The 9p21.3 region is particularly notable in genetic research for its consistent association with various metabolic and cardiovascular conditions, making it a frequent subject of genome-wide association studies (GWAS) aimed at understanding the complex genetic architecture of common diseases.
The Role of the CDKN2A/B Gene Region
The CDKN2A and CDKN2B genes are critical for regulating the cell cycle, which is the process by which cells grow and divide. Specifically, these genes encode proteins that act as inhibitors of cyclin-dependent kinases, effectively serving as 'brakes' on cell division. In the context of metabolic health, research suggests that variations in this region may influence the function of pancreatic beta-cells. These cells are responsible for producing and secreting insulin, the hormone that regulates blood sugar levels. When the regulation of these cells is impaired, it can affect insulin secretory function and overall beta-cell mass. By studying how variants like rs10810534 relate to these biological processes, scientists hope to better understand the underlying mechanisms that contribute to the development of type 2 diabetes.
Research Associations and Evidence Strength
The association between the 9p21.3 locus and type 2 diabetes is supported by numerous large-scale genome-wide association studies. Researchers have observed that certain alleles at this locus correlate with a slightly higher statistical risk of developing the condition. However, it is important to note that the evidence for any single SNP, including rs10810534, is considered limited in terms of its individual predictive power. Genetic risk for type 2 diabetes is polygenic, meaning it is influenced by the cumulative effect of many different variants, as well as significant environmental and lifestyle factors. While the statistical signal is robust across diverse populations, the variant does not act as a diagnostic tool. It serves as a piece of a much larger puzzle, helping researchers map the biological pathways involved in metabolic regulation rather than predicting an individual's health outcome.
Population Frequency and Interpretation
The rs10810534 variant is considered common, meaning it is found frequently across many different ancestral populations. Because it is a common variant, it is present in a large portion of the general population, regardless of whether they have been diagnosed with type 2 diabetes. This high frequency underscores the fact that having a particular genotype at this position is a normal part of human genetic diversity. When interpreting such data, it is essential to recognize that genetic associations are based on population-level statistics. These findings describe trends observed in large groups of people and cannot be used to determine an individual's personal risk or health status. Genetic information should always be viewed in the context of a comprehensive health assessment conducted by a qualified medical professional.
What You Can Do With This Information
Learning about your genetic variants can be an educational experience, but it is important to maintain a balanced perspective. Because the association between rs10810534 and type 2 diabetes is based on complex statistical models, this information is not a substitute for clinical advice. You cannot use this SNP to diagnose yourself or predict your future health. If you are concerned about your risk for type 2 diabetes, the most effective steps involve discussing your family history, lifestyle, and clinical markers—such as blood glucose levels—with your doctor. They can provide personalized guidance based on your overall health profile. Avoid making medical decisions based solely on genetic data, and always consult with a healthcare provider before making significant changes to your diet, exercise, or medical management plans.
How common is this variant?
The rs10810534 variant is a common polymorphism found across diverse global populations, with its various genotypes appearing frequently in the general public.
Frequently asked questions
Does having the rs10810534 variant mean I will get diabetes?
No. Genetic variants like rs10810534 only provide a small statistical increase in risk and do not determine whether you will develop a disease. Type 2 diabetes is influenced by many genes, as well as diet, physical activity, and other environmental factors.
Can I use this SNP to test my risk for diabetes?
No. Genetic testing for common variants is not a diagnostic tool for type 2 diabetes. Clinical diagnosis is based on blood tests, such as A1C or fasting glucose, performed by a healthcare provider.
Is the CDKN2A gene only related to diabetes?
No. The CDKN2A gene is primarily known for its role in cell cycle regulation and tumor suppression. Research into its role in diabetes is a specific area of metabolic study, but the gene has functions in many other biological processes.
Should I change my diet based on my rs10810534 genotype?
You should not change your diet based on a single genetic variant. Always consult with a doctor or a registered dietitian to create a nutrition plan that is appropriate for your overall health and medical history.
Sources & further reading
Educational information only, last refreshed 9/23/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10810534?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29